Search

everythinglearnresearchcommunity

for

Search:↓

Higher CRHR1 levels in AA patients lead to increased inflammation.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Targeting CD169+ skin macrophages may help treat psoriasis.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Targeting Vδ1+T-cells may help treat alopecia areata.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

IL-17 and certain immune cells are linked to more severe alopecia areata.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Special cells can help regrow hair in alopecia areata.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

The CTLA-4 gene change studied does not affect Polycystic Ovarian Syndrome in the women tested.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

The treatment was not recommended due to limited effectiveness and significant side effects.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

Murine cytomegalovirus does not cause alopecia areata in these mice.

γδ T cells are crucial for early wound healing after a skin virus infection.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.